MRL Ventures Fund LLC 4
4 · Translate Bio, Inc. · Filed Jul 3, 2018
Insider Transaction Report
Form 4
MRL Ventures Fund LLC
10% Owner
Transactions
- Conversion
Common Stock
2018-07-02+1,848,503→ 1,848,503 total - Conversion
Series C Preferred Stock
2018-07-02−1,010,101→ 0 total→ Common Stock (181,819 underlying) - Purchase
Common Stock
2018-07-02$13.00/sh+25,000$325,000→ 1,873,503 total - Conversion
Series B Preferred Stock
2018-07-02−9,259,259→ 0 total→ Common Stock (1,666,683 underlying)
Footnotes (1)
- [F1]The Series B and Series C Preferred Stock converted into Common Stock on a 5.5555-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.